Search Results for: GENE CELL THERAPY Its Growing
Articles
Editas Medicine Enters Into Strategic Partnership With Catalent to Support Gene-Editing Medicine Pipeline July 29, 2020
Editas Medicine, Inc. and Catalent recently announced they have entered into a strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical supply of….
GENE THERAPY - The Role Viral Vectors Play in Current Gene Therapy Development June 4, 2020
Dieter Lingelbach, MBA, discusses the history and science of viral vectors, their current applications, and why they are a vital component in contemporary gene therapy development.
MARKET BRIEF - Allergic Rhinitis Immunotherapy: Opportunity Analysis & Forecasts to 2028 March 30, 2020
Rose Joachim, PhD, indicates that while a wide variety of OTC therapies exist for the temporary abatement of AR symptoms, allergen-specific immunotherapy is the only truly disease-modifying therapy available for AR.
Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global February 3, 2020
Catalent, Inc. recently announced it has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an aggregate of…..
CONTINUOUS MANUFACTURING - Continuous Manufacturing in Pharmaceuticals: Implications for the Generics Market November 25, 2019
Kamna Jhamb, PhD, says the highly regulated nature of the pharmaceutical sector, and the low-risk-taking nature of this market, are the two main factors that have restrained the implementation of novel methods of manufacturing by pharmaceutical industries. However, the burgeoning demand for complex and innovative therapies and rising competition have led pharmaceutical manufacturers to reconsider their methods of manufacturing.
Imugene Announces First Patient Dosed in Open-Label Phase 2 Study March 14, 2019
Imugene Limited recently announced dosing of the first patient in an open-label, randomized multi-centre Phase 2 study with its HER-Vaxx...Mogrify Raises $3.7 Million to Accelerate Mission to Transform Cell Therapy Via Direct Cellular Conversion February 21, 2019
Cell Mogrify Ltd (Mogrify) recently announced a second close on its seed funding, bringing the total raised to $3.7 million,...TrakCel & Quick Partner to Provide Industry-Leading Digital Supply Chain IT Solution for Cell & Gene Therapies January 18, 2019
TrakCel and The Quick Life Science Group recently announced a partnership to offer an integrated IT logistics orchestration platform.
REGENERATIVE MEDICINE - Cell Therapy - The Quest for Finding the Cure November 12, 2018
Aarti Chitale, MBA, believes as the therapeutic landscape evolves and transitions toward personalized and value-based care, regenerative medicine will play an increasingly important role, and moreover, the success of these therapies offers promising opportunities for previously untreated diseases areas.
GENETIC MODIFICATION THERAPIES - Clinical Applications & Technology Platforms November 12, 2018
Laurie L. Sullivan and John Bergin, MS, MBA, say the growing interest on the part of large pharma or biotech companies is driving clinical development of genetic modification therapy candidates, and the rich late-stage pipeline for genetic modification therapy candidates is a driving force of growth.
THERAPEUTIC VACCINES - Exploring the Potential of Combining Cancer Vaccines With Immune Checkpoint Inhibitor Therapy November 12, 2018
Nina Baluja, MD, believes advances in our understanding of tumor immunology are rekindling interest in cancer vaccines, particularly in combination with breakthrough immunotherapies, such as immune checkpoint inhibitors.
EXECUTIVE INTERVIEW - BriaCell Therapeutics: Recognizing the Power of Targeted Immunotherapies October 1, 2018
Dr. William “Bill” Williams, MD, President and CEO of BriaCell Therapeutics, discusses the value of targeted immunotherapies in the biopharmaceutical industry.
Synteract Repositions Itself With Centers of Therapeutic Development & Unveils Updated Brand Platform April 23, 2018
Synteract recently announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma...BriaCell Presents Encouraging Clinical Data April 17, 2018
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company with a proprietary targeted immunotherapy technology, recently announced it presented a late-breaking poster...EXECUTIVE INTERVIEW - MilliporeSigma: Accelerating the Development & Manufacture of Gene Therapies, Immunotherapies & Viral Vaccines April 2, 2018
Dave Backer, Head of Virus & Gene Therapy Strategic Initiatives at MilliporeSigma, talks about his company’s expanding GMP capacity to speed development and manufacture of gene therapies, immunotherapies, and viral vaccines.
Avacta & Oncosec to Collaborate on Innovative Gene Delivery January 29, 2018
Avacta & Oncosec to Collaborate on Innovative Gene Delivery Avacta Group plc and OncoSec Medical Incorporated recently announced they have...GeoVax & Vaxeal to Collaborate on Cancer Immunotherapy Program January 8, 2018
GeoVax Labs, Inc. recently announced it is collaborating with Vaxeal Holding SA on the expansion of GeoVax’s cancer immunotherapy program....Inovio’s Cancer Immunotherapy Combined With Checkpoint Inhibitor Synergistically Shrinks Tumor & Improves Survival December 4, 2017
Inovio Pharmaceuticals, Inc. demonstrated the synergistic effect of combining Inovio’s TERT (telomerase reverse transcriptase) cancer immunotherapy in combination with a...Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study May 30, 2017
Inovio Pharmaceuticals, Inc. recently announced that its HIV vaccine, PENNVAX-GP, produced amongst the highest overall levels of immune response rates...EXECUTIVE INTERVIEW - PCT: Manufacturing the Future of Cell Therapies May 1, 2017
Robert A. Preti, PhD, discusses his company’s critical distinction from most other manufacturing partners, steady growth, and the primary challenges facing the cell therapy industry.
